IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes
- 1 January 2016
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 162, 45-48
Abstract
No abstract availableKeywords
Funding Information
- Sydvästra Skånes Diabetesförening (1040390)
- Skåne University Hospital Funding and Donations (1400741)
This publication has 22 references indexed in Scilit:
- CD4 T cells and their antigens in the pathogenesis of autoimmune diabetesCurrent Opinion in Immunology, 2011
- Gene expression analysis of dendritic cells that prevent diabetes in NOD mice: analysis of chemokines and costimulatory moleculesJournal of Leukocyte Biology, 2011
- Presence of GAD Antibodies During Gestational Diabetes Mellitus Predicts Type 1 DiabetesDiabetes Care, 2007
- The Role of the interleukin‐10 Subfamily Members in Immunoglobulin Production by Human B CellsScandinavian Journal of Immunology, 2006
- Gestational Diabetes Identifies Women at Risk for Permanent Type 1 and Type 2 Diabetes in Fertile AgeDiabetes Care, 2006
- Isotype Switching by Human B Cells Is Division-Associated and Regulated by CytokinesThe Journal of Immunology, 2002
- Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD miceEuropean Journal of Immunology, 2002
- Shifts in the TH1/TH2 Balance during Human Pregnancy Correlate with Apoptotic ChangesBiochemical and Biophysical Research Communications, 1998
- Prediction of Type 1 Diabetes Postpartum in Patients With Gestational Diabetes Mellitus by Combined Islet Cell Autoantibody Screening: A Prospective Multicenter StudyDiabetes, 1997
- Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in womenDiabetic Medicine, 1997